African American Women Who Receive Primary Anthracycline- and Taxane-Based Chemotherapy for Triple-Negative Breast Cancer Suffer Worse Outcomes Compared With White Women-Reference-Cited by-同舟云学术

African American Women Who Receive Primary Anthracycline- and Taxane-Based Chemotherapy for Triple-Negative Breast Cancer Suffer Worse Outcomes Compared With White Women

Published:2009-08-01 Issue:22 Volume:27 Page:e35-e37
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Balmanoukian Ani¹,Zhang Zhe¹,Jeter Stacie¹,Slater Shannon¹,Armstrong Deborah K.¹,Emens Leisha A.¹,Fetting John H.¹,Wolff Antonio C.¹,Davidson Nancy E.²,Jacobs Lisa³,Lange Julie³,Tsangaris Theodore N.³,Zellars Richard⁴,Gabrielson Edward⁵,Stearns Vered¹

Affiliation:

1. Department of Oncology and the Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD

2. University of Pittsburgh Cancer Institute, Pittsburgh, PA

3. Department of Surgery and the Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD

4. Department of Radiation Oncology and the Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD

5. Department of Pathology and the Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2008.21.5509

Reference7 articles.

1. Triple Receptor–Negative Breast Cancer: The Effect of Race on Response to Primary Systemic Treatment and Survival Outcomes

2. Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study

3. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA

4. Trends in Survival Over the Past Two Decades Among White and Black Patients With Newly Diagnosed Stage IV Breast Cancer

5. Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy;Journal of Clinical Oncology;2024-05-10

2. Machine learning prediction of pathological complete response and overall survival of breast cancer patients in an underserved inner-city population;Breast Cancer Research;2024-01-10

3. Epigenetic Profiles of Triple-Negative Breast Cancers of African American and White Females;JAMA Network Open;2023-10-05

4. Machine learning prediction of pathological complete response and overall survival of breast cancer patients in an underserved inner-city population;2023-09-29

5. Machine learning prediction of pathological complete response and overall survival of breast cancer patients in the Montefiore Health System in the Bronx;2023-09-12